# Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study

> **NCT04436419** · NA · COMPLETED · sponsor: **Fauqué** · enrollment: 40 (actual)

## Conditions studied

- Obesity
- Obesity, Abdominal
- Obesity, Visceral
- Female

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha lipoic acid (plus full hospitalization)
- **DIETARY_SUPPLEMENT:** Placebo (full hospitalization: dietary monitoring with an adapted physical activity program)

## Key facts

- **NCT ID:** NCT04436419
- **Lead sponsor:** Fauqué
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-02
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-03-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04436419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04436419, "Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04436419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*